Claire Cheymol is an expert in Oncology at Centre Oscar Lambret (France). Claire Cheymol has authored 13 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 1 of them ongoing. SLR score: 154 (community average: 125). How the SLR is computed.

LeadR Profile

Claire Cheymol Centre Oscar Lambret France
154 ScienceLeadR Reputation 154
Network Map

Oncology

Subspecialties: Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2018 - 2026

Source: PubMed

Centre Oscar Lambret

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 13

Citations

Citations: 20 1st author: 1 Last author: 1 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Cerebrospinal fluid circulating tumor DNA profiling in central nervous system metastases from solid tumors: A prospective multicentre translational analysis of the BrainStorm (OncoDistinct-006) study.
PMID 42835688 — genes, dna fingerprinting, circulating tumor dna, neoplasms, central nervous system, neoplasm metastasis, nervous system, tissues, plasma
J Liq Biopsy20260
Prognostic value of lymphopenia in early breast cancer: learnings from the prospective CANTO cohort.
PMID 42265714 — breast neoplasms, lymphocytes, lymphopenia, neoplasms, breast, therapeutics
Breast Cancer Res20260
[Brain metastases in breast cancer: Diagnosis and management].
PMID 40628551 — breast neoplasms, brain, neoplasms, neoplasm metastasis, breast, diagnosis, therapeutics
Bull Cancer20250
Conventional cytotoxic chemotherapy for gastrointestinal cancer in patients with cirrhosis: A multicentre case-control study.
PMID 38031969 — drug therapy, safety, liver, case-control studies, gastrointestinal neoplasms, chemotherapy
Liver Int20231
BrainStorm: a multicenter international study to tackle CNS metastases in solid tumors.
PMID 37857713 — molecular biology, neoplasm metastasis, neoplasms
Nat Med Top journal20230

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

N/A 3
Phase 2 1

By status:

Recruiting 3
Completed 1

By type:

Interventional 4

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 2

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo immunotherapy and Surgery
NCT05973864 — radiotherapy, injections, triple negative breast neoplasms, breast neoplasms, neoplasms, tablets, immunotherapy, breast, drug tapering, therapeutics, capecitabine
Phase 2Recruiting2025

LeadR Networks

Main global connection map